Investors are giddy before this morning's BG Med earnings call


Shares of BG Medicine (BGMD) are up 27% premarket. Management's Q4 earnings conference call starts momentarily.

The stock recently broke out of consolidation in response to improved reimbursement for its Gelectin-3 blood test.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs